Your browser doesn't support javascript.
loading
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Berdeja, Jesus G; Madduri, Deepu; Usmani, Saad Z; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D; Stewart, A Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred, Alicia J; Olyslager, Yunsi; Banerjee, Arnob; Jackson, Carolyn C; Goldberg, Jenna D; Schecter, Jordan M; Deraedt, William; Zhuang, Sen Hong; Infante, Jeffrey; Geng, Dong; Wu, Xiaoling; Carrasco-Alfonso, Marlene J; Akram, Muhammad; Hossain, Farah; Rizvi, Syed; Fan, Frank; Lin, Yi; Martin, Thomas; Jagannath, Sundar.
Afiliação
  • Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Madduri D; Mount Sinai Medical Center, New York, NY, USA.
  • Usmani SZ; Levine Cancer Institute-Atrium Health, Charlotte, NC, USA.
  • Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
  • Agha M; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Stewart AK; University Health Network and the Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Hari P; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Htut M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Lesokhin A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Deol A; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
  • Munshi NC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • O'Donnell E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Avigan D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Singh I; Janssen Research and Development, Spring House, PA, USA.
  • Zudaire E; Janssen Research and Development, Spring House, PA, USA.
  • Yeh TM; Janssen Research and Development, Raritan, NJ, USA.
  • Allred AJ; Janssen Research and Development, Spring House, PA, USA.
  • Olyslager Y; Janssen Research and Development, Beerse, Belgium.
  • Banerjee A; Janssen Research and Development, Spring House, PA, USA.
  • Jackson CC; Janssen Research and Development, Raritan, NJ, USA.
  • Goldberg JD; Janssen Research and Development, Raritan, NJ, USA.
  • Schecter JM; Janssen Research and Development, Raritan, NJ, USA.
  • Deraedt W; Janssen Research and Development, Beerse, Belgium.
  • Zhuang SH; Janssen Research and Development, Raritan, NJ, USA.
  • Infante J; Janssen Research and Development, Raritan, NJ, USA.
  • Geng D; Legend Biotech USA, Piscataway, NJ, USA.
  • Wu X; Legend Biotech USA, Piscataway, NJ, USA.
  • Carrasco-Alfonso MJ; Legend Biotech USA, Piscataway, NJ, USA.
  • Akram M; Legend Biotech USA, Piscataway, NJ, USA.
  • Hossain F; Legend Biotech USA, Piscataway, NJ, USA.
  • Rizvi S; Legend Biotech USA, Piscataway, NJ, USA.
  • Fan F; Nanjing Legend Biotechnology, Nanjing, China.
  • Lin Y; Mayo Clinic, Rochester, MN, USA.
  • Martin T; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Jagannath S; Mount Sinai Medical Center, New York, NY, USA. Electronic address: sundar.jagannath@mountsinai.org.
Lancet ; 398(10297): 314-324, 2021 07 24.
Article em En | MEDLINE | ID: mdl-34175021
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígeno de Maturação de Linfócitos B / Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígeno de Maturação de Linfócitos B / Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido